Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists
In: Bioorganic & medicinal chemistry letters (Print), Jg. 16 (2006), Heft 10, S. 2724-2728
academicJournal
- print,
Zugriff:
An imidazolylpyrimidine was identified in a CXCR2 chemokine receptor antagonist screen and was optimized for potency, in vitro metabolic stability, and oral bioavailability. It was found that subtle structural modification within the series affected the oral bioavailability. Potent and orally available CXCR2 antagonists are herein reported.
Titel: |
Imidazolylpyrimidine based CXCR2 chemokine receptor antagonists
|
---|---|
Autor/in / Beteiligte Person: | HO, Koc-Kan ; AULD, Douglas S ; LIU, Rong-Qiang ; MASTERSON, Christopher M ; OHLMEYER, Michael ; YAJING, RONG ; ROOSEBOOM, Martijn ; ROUGHTON, Andrew ; SAMAMA, Philippe ; SMIT, Martin-Jan ; SON, Ellen ; VAN DER LOUW, Jaap ; BOHNSTEDT, Adolph C ; VOGEL, Gerard ; WEBB, Maria ; WIJKMANS, Jac ; MING, YOU ; CONTI, Paolo ; DOKTER, Wim ; ERICKSON, Shawn ; DAMING, FENG ; INGLESE, Jim ; KINGSBURY, Celia ; KULTGEN, Steven G |
Link: | |
Zeitschrift: | Bioorganic & medicinal chemistry letters (Print), Jg. 16 (2006), Heft 10, S. 2724-2728 |
Veröffentlichung: | Oxford: Elsevier, 2006 |
Medientyp: | academicJournal |
Umfang: | print, |
ISSN: | 0960-894X (print) |
Schlagwort: |
|
Sonstiges: |
|